Subscribe free

Metabolic and Bariatric Surgery ·

Single Anastomosis Sleeve Ileal Bypass Shows Strong Results

Single anastomosis sleeve ileal bypass is a promising option for treating obesity and its related conditions.

  • Significant weight loss achieved: 63% at 6 months, 82% at 12 months, and 93% at 24 months.
  • High remission rates for conditions like diabetes (93%) and hypertension (79%).

Most complications are mild, with a mean rate of 14%. No reported deaths highlight its safety for patients.

Surgeons should consider SASI bypass as a viable choice for patients with a high BMI and multiple obesity-related comorbidities.

Journal Article by Rodrigues de Oliveira Filho J, Bregion PB (…) Griggs CL et 4 al. in Surg Endosc

© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

read the whole article in Surg Endosc

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Metabolic and Bariatric Surgery.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Metabolic and Bariatric Surgery

The latest stitches

Surg Endosc29 Sep 2026

Endoscopic Sleeve Gastroplasty Offers Safer Alternative to LSG

Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).

All papers in Metabolic and Bariatric Surgery →